View in EDS HTML Full Text PDF Full Text

Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.

Saved in:
Bibliographic Details
Title: Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Authors: Podany AT; University of Nebraska Medical Center, Omaha, Nebraska, USA., Pham M; University of Nebraska Medical Center, Omaha, Nebraska, USA., Sizemore E; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Martinson N; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Samaneka W; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Mohapi L; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Badal-Faesen S; University of Witwatersrand Helen Joseph CRS, Johannesburg, South Africa., Dawson R; University of Cape Town Lung Institute, Cape Town, South Africa., Johnson JL; Case Western Reserve University, Cleveland, Ohio, USA., Mayanja H; Uganda- Case Western Reserve University Research Collaboration, Kampala, Uganda., Lalloo U; Durban International Clinical Research Site, Durban, South Africa., Whitworth WC; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Pettit A; Vanderbilt University, Nashville, Tennessee, USA., Campbell K; University of Nebraska Medical Center, Omaha, Nebraska, USA.; University of Colorado, Denver, Colorado, USA., Phillips PPJ; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA., Bryant K; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Scott N; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Vernon A; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kurbatova EV; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chaisson RE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Dorman SE; Medical University of South Carolina, Columbia, South Carolina, USA., Nahid P; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA., Swindells S; University of Nebraska Medical Center, Omaha, Nebraska, USA., Dooley KE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Fletcher CV; University of Nebraska Medical Center, Omaha, Nebraska, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Sep 10; Vol. 75 (4), pp. 560-566.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34918028
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Podany+AT%22">Podany AT</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Pham+M%22">Pham M</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Sizemore+E%22">Sizemore E</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Martinson+N%22">Martinson N</searchLink>; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Samaneka+W%22">Samaneka W</searchLink>; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Mohapi+L%22">Mohapi L</searchLink>; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Badal-Faesen+S%22">Badal-Faesen S</searchLink>; University of Witwatersrand Helen Joseph CRS, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Dawson+R%22">Dawson R</searchLink>; University of Cape Town Lung Institute, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Johnson+JL%22">Johnson JL</searchLink>; Case Western Reserve University, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Mayanja+H%22">Mayanja H</searchLink>; Uganda- Case Western Reserve University Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Lalloo+U%22">Lalloo U</searchLink>; Durban International Clinical Research Site, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Whitworth+WC%22">Whitworth WC</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Pettit+A%22">Pettit A</searchLink>; Vanderbilt University, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+K%22">Campbell K</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.; University of Colorado, Denver, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Phillips+PPJ%22">Phillips PPJ</searchLink>; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Bryant+K%22">Bryant K</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Scott+N%22">Scott N</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Vernon+A%22">Vernon A</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Kurbatova+EV%22">Kurbatova EV</searchLink>; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Chaisson+RE%22">Chaisson RE</searchLink>; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Dorman+SE%22">Dorman SE</searchLink>; Medical University of South Carolina, Columbia, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Nahid+P%22">Nahid P</searchLink>; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Swindells+S%22">Swindells S</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Dooley+KE%22">Dooley KE</searchLink>; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fletcher+CV%22">Fletcher CV</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2022 Sep 10; Vol. 75 (4), pp. 560-566.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34918028
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciab1037
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 560
    Titles:
      – TitleFull: Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Podany AT
      – PersonEntity:
          Name:
            NameFull: Pham M
      – PersonEntity:
          Name:
            NameFull: Sizemore E
      – PersonEntity:
          Name:
            NameFull: Martinson N
      – PersonEntity:
          Name:
            NameFull: Samaneka W
      – PersonEntity:
          Name:
            NameFull: Mohapi L
      – PersonEntity:
          Name:
            NameFull: Badal-Faesen S
      – PersonEntity:
          Name:
            NameFull: Dawson R
      – PersonEntity:
          Name:
            NameFull: Johnson JL
      – PersonEntity:
          Name:
            NameFull: Mayanja H
      – PersonEntity:
          Name:
            NameFull: Lalloo U
      – PersonEntity:
          Name:
            NameFull: Whitworth WC
      – PersonEntity:
          Name:
            NameFull: Pettit A
      – PersonEntity:
          Name:
            NameFull: Campbell K
      – PersonEntity:
          Name:
            NameFull: Phillips PPJ
      – PersonEntity:
          Name:
            NameFull: Bryant K
      – PersonEntity:
          Name:
            NameFull: Scott N
      – PersonEntity:
          Name:
            NameFull: Vernon A
      – PersonEntity:
          Name:
            NameFull: Kurbatova EV
      – PersonEntity:
          Name:
            NameFull: Chaisson RE
      – PersonEntity:
          Name:
            NameFull: Dorman SE
      – PersonEntity:
          Name:
            NameFull: Nahid P
      – PersonEntity:
          Name:
            NameFull: Swindells S
      – PersonEntity:
          Name:
            NameFull: Dooley KE
      – PersonEntity:
          Name:
            NameFull: Fletcher CV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 09
              Text: 2022 Sep 10
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 75
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1